FI920180A0 - Foerfarande foer framstaellning av (6s) - och (6r)-tetrahydrofolsyra. - Google Patents

Foerfarande foer framstaellning av (6s) - och (6r)-tetrahydrofolsyra.

Info

Publication number
FI920180A0
FI920180A0 FI920180A FI920180A FI920180A0 FI 920180 A0 FI920180 A0 FI 920180A0 FI 920180 A FI920180 A FI 920180A FI 920180 A FI920180 A FI 920180A FI 920180 A0 FI920180 A0 FI 920180A0
Authority
FI
Finland
Prior art keywords
acid
tetrahydrofolic
addition salts
tetrahydrofolsyra
och
Prior art date
Application number
FI920180A
Other languages
English (en)
Other versions
FI920180A (fi
FI109906B (fi
Inventor
Hans Rudolf Mueller
Martin Ulmann
Josef Conti
Guenter Muerdel
Original Assignee
Eprova Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eprova Ag filed Critical Eprova Ag
Publication of FI920180A0 publication Critical patent/FI920180A0/fi
Publication of FI920180A publication Critical patent/FI920180A/fi
Application granted granted Critical
Publication of FI109906B publication Critical patent/FI109906B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Piezo-Electric Or Mechanical Vibrators, Or Delay Or Filter Circuits (AREA)
  • Liquid Crystal Substances (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Steroid Compounds (AREA)
FI920180A 1991-01-16 1992-01-15 Menetelmä (6S)- ja (6R)-tetrahydrofoolihapon valmistamiseksi FI109906B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH108/91A CH681303A5 (fi) 1991-01-16 1991-01-16
CH10891 1991-01-16

Publications (3)

Publication Number Publication Date
FI920180A0 true FI920180A0 (fi) 1992-01-15
FI920180A FI920180A (fi) 1992-07-17
FI109906B FI109906B (fi) 2002-10-31

Family

ID=4179454

Family Applications (1)

Application Number Title Priority Date Filing Date
FI920180A FI109906B (fi) 1991-01-16 1992-01-15 Menetelmä (6S)- ja (6R)-tetrahydrofoolihapon valmistamiseksi

Country Status (25)

Country Link
US (1) US5324836A (fi)
EP (1) EP0495204B1 (fi)
JP (1) JPH0739417B2 (fi)
KR (1) KR100207133B1 (fi)
CN (1) CN1030079C (fi)
AT (1) ATE123777T1 (fi)
AU (1) AU654993B2 (fi)
CA (1) CA2059103C (fi)
CH (1) CH681303A5 (fi)
DE (1) DE59105722D1 (fi)
DK (1) DK0495204T3 (fi)
ES (1) ES2075315T3 (fi)
FI (1) FI109906B (fi)
GE (1) GEP19971019B (fi)
HU (1) HU207083B (fi)
IE (1) IE72164B1 (fi)
IL (1) IL100478A (fi)
LV (1) LV10083B (fi)
MX (1) MX9200063A (fi)
NO (1) NO301422B1 (fi)
NZ (1) NZ241245A (fi)
PT (1) PT100014B (fi)
RU (1) RU2099340C1 (fi)
TW (1) TW198033B (fi)
ZA (1) ZA92291B (fi)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH682664A5 (en) * 1991-10-15 1993-10-29 Eprova Ag Stable salts of 5,10-methylene tetrahydrofolate.
DE4136921A1 (de) * 1991-11-11 1993-05-13 Knoll Ag Verfahren zur trennung von 5-methyl-tetrahydrofolsaeure
CH683262A5 (it) * 1992-01-22 1994-02-15 Applied Pharma Res Procedimento per la separazione dei diastereomeri del sale di calcio dell'acido (6(R,S)-N-formiltetraidrofolico).
IT1254635B (it) * 1992-02-20 1995-09-28 Bracco Spa Processo per la separazione degli stereoisomeri dell'acido folinico
CH684644A5 (de) 1992-07-13 1994-11-15 Eprova Ag 5,10-Methylentetrahydrofolsäure-Cyclodextrin-Einschlussverbindungen.
CH686672A5 (de) * 1992-12-01 1996-05-31 Cerbios Pharma Sa Verfahren zur Herstellung von (6S)-5,6,7,8-Tetrahydrofolsaeure.
CH686369A5 (de) * 1994-05-09 1996-03-15 Eprova Ag Stabile kristalline (6S)- und (6R)-Tetrahydrofolseure.
CH689831A5 (de) * 1995-11-07 1999-12-15 Eprova Ag Stabile kristalline Tetrahydrofolsaeure-Salze.
CH693905A5 (de) 1999-04-15 2004-04-15 Eprova Ag Stabile kristalline Salze von 5-Methyltetrahydrofolsäure.
CH695217A5 (de) * 1999-07-14 2006-01-31 Merck Eprova Ag Verfahren zur Trennung optischer Isomeren von Tetrahydrofolsäureestersalzen und Tetrahydrofolsäure.
CH694251A5 (de) * 1999-07-14 2004-10-15 Eprova Ag Herstellung von Tetrahydropterin und Derivaten.
AU2002241918B2 (en) 2001-01-16 2007-01-18 Gr Intellectual Reserve, Llc Enhanced data storage and retrieval devices and systems and methods for utilizing the same
ITMI20020132A1 (it) 2002-01-25 2003-07-25 Gmt Fine Chemicals Sa Processo per l'ottenimento dell'acido (6s)-5,6,7,8-tetraidrofolico
AU2003303150A1 (en) 2002-11-21 2004-07-14 Berkshire Laboratories, Inc. Enhanced data storage and retrieval devices and systems and methods for utilizing same
CH696717A5 (de) * 2004-02-20 2007-10-31 Cerbios Pharma Sa Konzentrierte, stabile Losung, insbesondere eine Injektionslosung oder Infusionslosung, welche nebst Wasser entweder (6S)-Natrium-Folinat oder (6S)-Kalium-Folinat entholt
CH698729B1 (de) * 2007-05-30 2009-10-15 Cerbios Pharma Sa Stabile, kristalline (6S)-N(5)-Methyl-5, 6,7,8-tetrahydrofolsäure.
CN101407518A (zh) * 2007-10-11 2009-04-15 南京莱尔生物化工有限公司 (6r,s)-5-甲酰-四氢叶酸的拆分及其成盐的方法
JP5925381B2 (ja) 2012-04-13 2016-05-25 ▲連雲▼港金康和信▲薬業▼有限公司Ｌｉａｎｙｕｎｇａｎｇ Ｊｉｎｋａｎｇ Ｈｅｘｉｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｃｏ．， Ｌｔｄ． 化合物［４−（２−アミノ−１０−メチル−４−オキソ−６，７，８，９−テトラヒドロ−４ａ，７−エピミノピリミド［４，５−ｂ］［１，４］ジアゼピン−５（４Ｈ）−イル）ベンゾイル］−グルタメート及びその製造
CN104045640B (zh) * 2013-03-14 2016-04-06 天津康鸿医药科技发展有限公司 一种制备高纯度左亚叶酸钙的方法
CN104774169B (zh) * 2014-01-15 2017-02-15 上海韶远试剂有限公司 一种利用非手性助剂进行非对映异构体拆分的新方法
CN108164531B (zh) * 2018-02-12 2019-11-05 江苏红豆杉药业有限公司 一种l-5-甲基四氢叶酸钙的制备方法
CN112351818A (zh) 2018-07-06 2021-02-09 默克专利股份有限公司 5-甲基-(6s)-四氢叶酸和l-异亮氨酸乙酯的结晶盐

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3468886A (en) * 1967-10-23 1969-09-23 Us Health Education & Welfare Tetrahydrohomofolic acid sulfate and synthesis thereof
DE2063027A1 (de) * 1969-12-26 1971-07-01 Yamanouchi Pharmaceutical Co Ltd , Tokio Salz einer basischen Aminosäure der 5 6,7,8 Tetrahydrofolsaure
JPS4832120A (fi) * 1971-08-31 1973-04-27
US4665176A (en) * 1984-10-23 1987-05-12 Mitsui Toatsu Chemicals, Incorporated Process for the preparation of 5,6,7,8-tetrahydrofolic acid
GB8621268D0 (en) * 1986-09-03 1986-10-08 Univ Strathclyde Separation of substances
CH673459A5 (fi) * 1987-05-15 1990-03-15 Eprova Ag
DE3821875C1 (fi) * 1988-06-29 1990-02-15 Eprova Ag, Forschungsinstitut, Schaffhausen, Ch
JPH0265787A (ja) * 1988-08-30 1990-03-06 Kyowa Hakko Kogyo Co Ltd Ｌ（‐）‐テトラヒドロ葉酸の製造法
CH676981A5 (fi) * 1988-11-11 1991-03-28 Eprova Ag
FR2643081B1 (fr) * 1989-02-14 1991-06-07 Panmedica Sa Folates de magnesium, procede de preparation et compositions pharmaceutiques
US5173488A (en) * 1989-08-21 1992-12-22 American Cyanamid Company Stable injectable pharmaceutical formulation for folic acid and leucovorin salts and method
DE69027585T2 (de) * 1989-12-11 1997-01-16 American Cyanamid Co Verfahren zur Herstellung von optisch reinen Diastereoisomeren von Tetrahydrofolatverbindungen
CH680731A5 (fi) * 1990-04-12 1992-10-30 Sapec Fine Chemicals

Also Published As

Publication number Publication date
LV10083A (lv) 1994-05-10
CN1063285A (zh) 1992-08-05
CN1030079C (zh) 1995-10-18
HUT60272A (en) 1992-08-28
HU9200134D0 (en) 1992-04-28
TW198033B (fi) 1993-01-11
NO920197D0 (no) 1992-01-15
FI920180A (fi) 1992-07-17
ZA92291B (en) 1992-09-30
RU2099340C1 (ru) 1997-12-20
GEP19971019B (en) 1997-05-22
IE72164B1 (en) 1997-03-26
NO301422B1 (no) 1997-10-27
FI109906B (fi) 2002-10-31
KR920014812A (ko) 1992-08-25
EP0495204A1 (de) 1992-07-22
US5324836A (en) 1994-06-28
PT100014A (pt) 1993-03-31
NO920197L (no) 1992-07-17
LV10083B (en) 1995-04-20
ES2075315T3 (es) 1995-10-01
IL100478A0 (en) 1992-09-06
JPH04312586A (ja) 1992-11-04
KR100207133B1 (ko) 1999-07-15
MX9200063A (es) 1993-01-01
CA2059103C (en) 1996-12-17
EP0495204B1 (de) 1995-06-14
CA2059103A1 (en) 1992-07-17
IE920112A1 (en) 1992-07-29
HU207083B (en) 1993-03-01
AU654993B2 (en) 1994-12-01
DE59105722D1 (de) 1995-07-20
CH681303A5 (fi) 1993-02-26
DK0495204T3 (da) 1995-08-07
IL100478A (en) 1999-03-12
NZ241245A (en) 1993-11-25
ATE123777T1 (de) 1995-06-15
AU1025492A (en) 1992-07-23
JPH0739417B2 (ja) 1995-05-01
PT100014B (pt) 1999-08-31

Similar Documents

Publication Publication Date Title
FI920180A0 (fi) Foerfarande foer framstaellning av (6s) - och (6r)-tetrahydrofolsyra.
NO874350D0 (no) Fremgangsmaate for fremstilling av antibakterielle forbindelser.
HUT53364A (en) Process for producing new 2-aminopyrimidinone derivatives and pharmaceutical compositions comprising same as active ingredient
DE3873578T2 (de) Verwendung von tetrahydrobenz(c,d)indol-6-carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
AU2868689A (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
KR100271416B1 (en) Carbamate derivatives of 4-amino-3-isoxazolidinones,3-amino-1-hydroxypyrrolidin-2-ones and1-amino-1-cyclopropanecarboxylic acid analogs, aprocess for their preparation and a pharmaceuticalcomposition comprising the same
DE3855520T2 (de) Methode zur Verbesserung des Schlafes
JPS6442472A (en) Quinazoline derivative, production thereof and brain function disorder improving agent containing said derivative as active ingredient
HUT53064A (en) Process for producing 2,6-dichlorophenyl aminophenylacetic acid derivatives
FI864970A (fi) Nya kristallina salter av aryloxi-propanolaminer, foerfarande foer deras framstaellning och deras anvaendning.
HUT51597A (en) Process for production of derivatives of n,n-disubstituated diaryl-alcane-carbonic acid amid and medical compositions containing them as active substances
HUT64355A (en) Process for producing amino-methane-phosphonic acid and amino-methane-phosphinic one
ES2066052T3 (es) Esteres del acido cinamico.
HUT43578A (en) Process for production of derivatives of 1,3-oxotian and medical compounds containing thereof
ZA891769B (en) Heterocyclic compounds
HUT47900A (en) Process for producing new amides of butenic acid and pharmaceutical compositions containing them as active components